| KEPPEL HEALTHCARE LTD. |
| Registered number: |
03341325 |
| Balance Sheet |
| as at 31 March 2025 |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Fixed assets |
| Tangible assets |
3 |
|
|
9,007,983 |
|
|
9,000,000 |
|
| Current assets |
| Debtors |
4 |
|
258,201 |
|
|
236,099 |
| Cash at bank and in hand |
|
|
29,377 |
|
|
240,019 |
|
|
|
287,578 |
|
|
476,118 |
|
| Creditors: amounts falling due within one year |
5 |
|
(1,954,933) |
|
|
(916,904) |
|
| Net current liabilities |
|
|
|
(1,667,355) |
|
|
(440,786) |
|
| Total assets less current liabilities |
|
|
|
7,340,628 |
|
|
8,559,214 |
|
| Creditors: amounts falling due after more than one year |
6 |
|
|
- |
|
|
(1,546,382) |
|
| Provisions for liabilities |
|
|
|
(890,554) |
|
|
(893,548) |
|
|
| Net assets |
|
|
|
6,450,074 |
|
|
6,119,284 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Revaluation reserve |
7 |
|
|
2,680,643 |
|
|
2,680,643 |
| Profit and loss account |
|
|
|
3,769,331 |
|
|
3,438,541 |
|
| Shareholders' funds |
|
|
|
6,450,074 |
|
|
6,119,284 |
|
|
|
|
|
|
|
|
| The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| Dr Tariq Mahmood Chauhan |
| Director |
| Approved by the board on 22 December 2025 |
|
| KEPPEL HEALTHCARE LTD. |
| Notes to the Accounts |
| for the year ended 31 March 2025 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Freehold buildings |
Nil |
|
Fixtures, fittings, tools and equipment |
over 3 years |
|
|
Impairment |
|
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceed the recoverable amount, the asset is impaired accrodingly. Prior impairment are also reviewed for possible reversal at each reporting date. |
|
When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash generating unit to which the asset belongs. The cash generating unit is the smallest identifiable group of asset that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. |
|
|
Financial instruments |
|
A financial asset or financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, in which case they are recognised at the present value of future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are subsequently measured at fair value (with changes recognised in profit or loss) where they are publicly traded or where fair value can otherwise be measured reliably; all other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a non-market rate of interest, in which case the asset is measured at the present value of future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with changes recognised in profit or loss, except for hedging instruments in a designated hedging relationship. |
|
Financial assets measured at cost or amortised cost are reviewed for objective evidence of impairment at each reporting date and, where such evidence exists, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other individually significant financial assets are assessed individually for impairment, while other financial assets are assessed either individually or grouped based on similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not increase the carrying amount of the financial asset above what it would have been had the impairment not previously been recognised. |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
Provisions |
|
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. |
|
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
2 |
|
2 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Tangible fixed assets |
|
|
|
|
Land and buildings |
|
Plant and machinery etc |
|
Total |
| £ |
£ |
£ |
|
Cost |
|
At 1 April 2024 |
9,000,000 |
|
- |
|
9,000,000 |
|
Additions |
- |
|
11,975 |
|
11,975 |
|
At 31 March 2025 |
9,000,000 |
|
11,975 |
|
9,011,975 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
Charge for the year |
- |
|
3,992 |
|
3,992 |
|
At 31 March 2025 |
- |
|
3,992 |
|
3,992 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 March 2025 |
9,000,000 |
|
7,983 |
|
9,007,983 |
|
At 31 March 2024 |
9,000,000 |
|
- |
|
9,000,000 |
|
|
|
|
|
|
|
|
|
|
|
Freehold land and buildings: |
2025 |
|
2024 |
| £ |
£ |
|
Historical cost |
5,425,809 |
|
5,425,809 |
|
Cumulative depreciation based on historical cost |
- |
|
- |
|
|
|
|
|
|
5,425,809 |
|
5,425,809 |
|
|
| 4 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade debtors |
78,201 |
|
198,268 |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
180,000 |
|
- |
|
Other debtors |
- |
|
37,831 |
|
|
|
|
|
|
258,201 |
|
236,099 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Bank loans and overdrafts |
1,606,017 |
|
283,106 |
|
Taxation and social security costs |
168,790 |
|
174,963 |
|
Other creditors |
174,501 |
|
153,210 |
|
Rent Deposit |
5,625 |
|
5,625 |
|
Amounts due to connected parties |
- |
|
300,000 |
|
|
|
|
|
|
1,954,933 |
|
916,904 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Creditors: amounts falling due after one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Bank loans |
- |
|
1,546,382 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Revaluation reserve |
2025 |
|
2024 |
| £ |
£ |
|
|
At 1 April 2024 |
2,680,643 |
|
2,680,643 |
|
|
At 31 March 2025 |
2,680,643 |
|
2,680,643 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Other information |
|
|
KEPPEL HEALTHCARE LTD. is a private company limited by shares and incorporated in England. Its registered office is: |
|
9 Retiro Street |
|
Oldham |
|
OL1 1SA |